PEL

Piramal Enterprises Limited has informed the Exchange regarding a press release dated 29th July, 2025, titled "Press Release ".".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 06, 2025, titled "Piramal Enterprises Limited has informed the Exchange regarding a press release dated 6th May, 2025, titled "Press Release ".".

"Piramal Enterprises Limited has informed the Exchange regarding press release dated 6th May, 2025".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 27, 2025

Piramal Enterprises Limited has informed the Exchange regarding a press release dated October 23, 2024, titled "Press Release ".

Piramal Enterprises Limited has informed the Exchange about Deed of conveyance executed between Piramal Capital & Housing Finance Limited, wholly-owned subsidiary of the Company and Shoquba Realty Private Limited for sale of immoveable property

Press Release - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2024.

Piramal Enterprises Limited has informed the Exchange regarding a press release dated Jun 18, 2024.

Piramal Enterprises Limited has informed the Exchange regarding a press release dated Jun 18, 2024

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 08, 2024

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 29, 2024, titled "Press Release ".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated November 09, 2023, titled "Press Release and Investor Presentation Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September, 2023".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated July 28, 2023, titled "Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and ended 30th June, 2023".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 05, 2023, titled "Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended 31st March, 2023".

Intimation under Regulations 30 and 51 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Securities and Exchange Board of India���s circular no. CIR/CFD/CMD/4/2015 dated September 9, 2015

Piramal Enterprises Limited has informed the Exchange about Diversification/Disinvestment

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 22, 2020, titled "Piramal Enterprises Limited Rights Issue Over-Subscribed 1.14 Times".

Piramal Enterprises Limited has informed the Exchange about Diversification/Disinvestment

Piramal Enterprises Limited has informed the Exchange regarding a press release dated October 25, 2019, titled "Piramal Enterprises Raises Capital of INR 5,400 Crores (US$ 770mn) ".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated July 30, 2019, titled "Press Release on the Unaudited Financial Results for the quarter ended 30th June, 2019".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 07, 2019, titled "Piramal Enterprises Limited Signs MoU with Canada Pension Plan Investment Board; Sets up Asset Aggregation Platform Focused on RenewablesPiramal Enterprises Limited Signs MoU with Canada Pension Plan Investment Board; Sets up Asset Aggregation Platform Focused on Renewables".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated March 12, 2019, titled "Piramal Announces the Launch of Cinacalcet by its Partner, Slate Run Pharmaceuticals, in the U.S. ".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated March 11, 2019, titled "Piramal Critical Care announces the U.S. launch of MITIGO".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated February 21, 2019, titled "Supreme Court Exempts Saridon from the List of Banned FDCs".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated October 21, 2018, titled "Piramal Enterprises categorically Refutes Baseless Rumours on Real Estate Lending Portfolio".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated August 16, 2017, titled "Decision Resources Inc., wholly owned subsidiary of Piramal Enterprises Limited acquires Context Matters Inc. ".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated March 20, 2017, titled "Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC.".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated February 23, 2017, titled "Piramal Enterprises Limited and Ivanho Cambridge Announce Partnership to Invest in Residential Development in India".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 30, 2017, titled "Piramal Enterprises announces Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 05, 2017, titled "Piramal Enterprises Limited announces its plan to enter housing finance".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated October 10, 2016, titled "Piramal Enterprises' Critical Care Division expands its product portfolio; enters into an agreement to acquire Janssen's injectable anesthesia and pain management products".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated August 16, 2016 titled "Piramal Enterprises enters into an agreement to acquire US based CDMO for High Potency APIs (HPAPIs), Ash Stevens Inc.".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated August 1, 2016 titled "Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016 ".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 16, 2016 titled "Consolidated Results for the Q4 FY2016 and FY2016".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 13, 2016 titled "Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated February 29, 2016 titled "Decision Resources Group Expands into Healthcare Payer Market".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated February 08, 2016, titled "Piramal Enterprises Limited Consolidated Results for the Q3 FY2016 and 9M FY2016".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 12, 2016 titled "Piramal Enterprises announces sale of its Canada-based cartilage repair product, BST-CarGel to Smith & Nephew".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated December 22, 2015, titled "Piramal Enterprises acquires five brands from Organon India Pvt.Ltd. (OIPL) and MSD BV for its Consumer Products Business"

Piramal Enterprises Limited regarding a press release dated November 02, 2015 titled "Piramal Enterprises Limited Consolidated Results for the Q2 FY2016 and H1 FY2016".

Piramal Enterprises Limited has informed the Exchange regarding a Press Release dated August 06, 2015 titled '' Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2015 "

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 7, 2015 titled "Piramal Enterprises Consolidated Results for the Fourth Quarter and Full Year ended 31 March 2015 ".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated April 17, 2015, titled "Piramal Enterprises Limited agrees to acquire majority equity stake in Health SuperHiway Private Limited".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated April 01, 2015 titled "Piramal Enterprises announces sale of its Hyderabad based Clinical Research Division to Indoco Remedies".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated February 9, 2015 titled "Piramal Enterprises Consolidated Results for the Third Quarter and Nine Months ended 31 December 2014".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 16, 2015 titled "Piramal Enterprises acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 15, 2015 titled "Piramal Enterprises considers potential acquisition of Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated October 21, 2014 titled "Piramal Enterprises announces Q2 & H1FY2015 results".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated August 27, 2014, titled, "Piramal Enterprises enters into a Joint Venture with Navin Fluorine for specialty Fluorochemicals with applications in healthcare".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated August 06, 2014 with respect to the Unaudited Financial Results (consolidated and standalone) of the Company for the quarter ended June 30, 2014.